Appendix - CNIC
Appendix - CNIC
Appendix - CNIC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
SCIENTIFIC REPORT ´09<br />
Genomics<br />
> RESEARCH INTEREST<br />
Head of Unit: Ana Dopazo<br />
Support Scientists: Sergio Callejas<br />
Alberto Benguría<br />
Fátima Sánchez Cabo<br />
Technician: Rebeca Álvarez<br />
The Genomics Unit is dedicated to providing high-quality<br />
genomic technology to the scientific community at the <strong>CNIC</strong><br />
and beyond. The Unit is equipped with Agilent and<br />
Affymetrix microarray platforms, the world’s leading DNA<br />
chip technologies, and has extensive experience in the use of<br />
array-based technologies for genome studies. The Unit’s<br />
expertise encompasses all the steps required for these highthroughput<br />
approaches, including experimental design,<br />
sample preparation and processing, and statistical data<br />
analysis.<br />
Major services and array-based applications include wholegenome<br />
differential gene expression analysis (including at<br />
the exon level) and microRNA expression analysis. The Unit’s<br />
service portfolio has recently been expanded to incorporate<br />
comparative genomic hybridization (CGH) arrays, a powerful<br />
79<br />
7 Technical Units<br />
tool for the genome-wide detection of copy number<br />
variations. Other services include the maintenance and<br />
management of real-time PCR instruments (one AB 7000<br />
and two ABI 7900HT machines) and a TaqMan array<br />
processing service. The Unit also provides user advice and<br />
training on topics related to the Unit’s activity, particularly<br />
experimental design and statistical data analysis for qPCR<br />
and microarray experiments.<br />
The Genomics Unit actively participates in one of the ongoing<br />
<strong>CNIC</strong> clinical projects, the IM-JOVEN study. IM-JOVEN is<br />
part of a large, multicenter case-controlled study aimed at<br />
identifying the clinical, genetic and demographic<br />
characteristics that determine the occurrence of myocardial<br />
infarction in young women.